Ticker Scorecard - LRMR Basics Company: Larimar Therapeutics, Inc. Common Stock IPO Date: July 1, 2014 Sector: Healthcare Industry: Biotech Market Cap: $203.54M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.75% Avg Daily Range (30 D): $0.11 | 3.09% Avg Daily Range (90 D): $0.20 | 3.55% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .5M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 107 Avg Trade Size (Sh.) (30 D): 115 Avg Trade Size (Sh.) (90 D): 103 Institutional Trades Total Inst.Trades: 153 Avg Inst. Trade: $1.77M Avg Inst. Trade (30 D): $.74M Avg Inst. Trade (90 D): $1.74M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.09M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 298.26K     News Sep 19, 2024 @ 11:00 AM Larimar Therapeutics Announces Three Poster Presen... Source: N/A May 29, 2024 @ 12:45 PM 2 Potentially High-Reward Growth Stocks to Buy Rig... Source: newsfeedback@fool.com (George Budwell) May 24, 2024 @ 1:38 PM The Zacks Analyst Blog Highlights Biogen, Ionis Ph... Source: Zacks Equity Research May 23, 2024 @ 4:46 PM Biotech Stock Roundup: BIIB's Acquisition, PTCT, L... Source: Zacks Equity Research May 22, 2024 @ 3:25 PM Larimar (LRMR) Up on Lifting of Partial Clinical H... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.24 $-.34 $-.27 Diluted EPS $-.24 $-.34 $-.27 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -15.5M $ -21.63M $ -14.65M Operating Income / Loss $ -18.26M $ -24.6M $ -16.73M Cost of Revenue $ $ $ Net Cash Flow $ 2.76M $ -77.81M $ 83.38M PE Ratio